| Dr Darlene Erica Gou, MD | |
|
8080 Independence Pkwy Ste 150, Plano, TX 75025-4006 | |
| (214) 919-3500 | |
| (214) 842-8055 |
| Full Name | Dr Darlene Erica Gou |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 9 Years |
| Location | 8080 Independence Pkwy Ste 150, Plano, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245627082 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | S1107 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthtexas Provider Network | 1355254210 | 1810 |
| Pdp Of Texas, Pllc | 2466455050 | 57 |
News Archive
Watson Pharmaceuticals, Inc. has confirmed that it has filed two Abbreviated New Drug Applications (ANDAs) with the U.S. Food and Drug Administration seeking approval to market its guaifenesin extended-release 600mg and 1200mg tablets and its dextromethorphan HBr/guaifenesin extended-release 30mg/600mg and 60mg/1200mg tablets prior to the expiration of patents owned by Reckitt Benckiser Inc.
NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy (WAVE) platform technology to treat endourological conditions, is pleased to announce it has received FDA 510(k) clearance of the company's Rezūm System to treat BPH.
Iron Mountain Incorporated, the information management company, today announced that the Texas Regional Medical Center (TRMC) has chosen Iron Mountain's vendor neutral archive (VNA) and cloud storage solution to manage its CT scans, MRIs, X-rays and other diagnostic image volume.
Atrial fibrillation is a cardiac arrhythmia - a chronic irregularity of heartbeat - which affects an estimated 1 million people in Germany. Although the condition is not acutely life-threatening, it does increase the risk of developing more serious illnesses, such as cardiac insufficiency, stroke and dementia. In the third of a series of genomewide asssociation studies, an international team of researchers, led by LMU physician PD Dr. Stefan K-b, now reports the identification of a new gene locus that has a significant influence on risk for atrial fibrillation.
There is good news for cancer patients whose medical treatments put them at risk for future cardiac problems: using strain echocardiography can help physicians detect early signs of cardiac toxicity.
› Verified 1 days ago
| Entity Name | Healthtexas Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760488936 PECOS PAC ID: 1355254210 Enrollment ID: O20040727001187 |
News Archive
Watson Pharmaceuticals, Inc. has confirmed that it has filed two Abbreviated New Drug Applications (ANDAs) with the U.S. Food and Drug Administration seeking approval to market its guaifenesin extended-release 600mg and 1200mg tablets and its dextromethorphan HBr/guaifenesin extended-release 30mg/600mg and 60mg/1200mg tablets prior to the expiration of patents owned by Reckitt Benckiser Inc.
NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy (WAVE) platform technology to treat endourological conditions, is pleased to announce it has received FDA 510(k) clearance of the company's Rezūm System to treat BPH.
Iron Mountain Incorporated, the information management company, today announced that the Texas Regional Medical Center (TRMC) has chosen Iron Mountain's vendor neutral archive (VNA) and cloud storage solution to manage its CT scans, MRIs, X-rays and other diagnostic image volume.
Atrial fibrillation is a cardiac arrhythmia - a chronic irregularity of heartbeat - which affects an estimated 1 million people in Germany. Although the condition is not acutely life-threatening, it does increase the risk of developing more serious illnesses, such as cardiac insufficiency, stroke and dementia. In the third of a series of genomewide asssociation studies, an international team of researchers, led by LMU physician PD Dr. Stefan K-b, now reports the identification of a new gene locus that has a significant influence on risk for atrial fibrillation.
There is good news for cancer patients whose medical treatments put them at risk for future cardiac problems: using strain echocardiography can help physicians detect early signs of cardiac toxicity.
› Verified 1 days ago
| Entity Name | Pdp Of Texas, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629025739 PECOS PAC ID: 2466455050 Enrollment ID: O20060822000094 |
News Archive
Watson Pharmaceuticals, Inc. has confirmed that it has filed two Abbreviated New Drug Applications (ANDAs) with the U.S. Food and Drug Administration seeking approval to market its guaifenesin extended-release 600mg and 1200mg tablets and its dextromethorphan HBr/guaifenesin extended-release 30mg/600mg and 60mg/1200mg tablets prior to the expiration of patents owned by Reckitt Benckiser Inc.
NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy (WAVE) platform technology to treat endourological conditions, is pleased to announce it has received FDA 510(k) clearance of the company's Rezūm System to treat BPH.
Iron Mountain Incorporated, the information management company, today announced that the Texas Regional Medical Center (TRMC) has chosen Iron Mountain's vendor neutral archive (VNA) and cloud storage solution to manage its CT scans, MRIs, X-rays and other diagnostic image volume.
Atrial fibrillation is a cardiac arrhythmia - a chronic irregularity of heartbeat - which affects an estimated 1 million people in Germany. Although the condition is not acutely life-threatening, it does increase the risk of developing more serious illnesses, such as cardiac insufficiency, stroke and dementia. In the third of a series of genomewide asssociation studies, an international team of researchers, led by LMU physician PD Dr. Stefan K-b, now reports the identification of a new gene locus that has a significant influence on risk for atrial fibrillation.
There is good news for cancer patients whose medical treatments put them at risk for future cardiac problems: using strain echocardiography can help physicians detect early signs of cardiac toxicity.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Darlene Erica Gou, MD 8080 Independence Pkwy Ste 150, Plano, TX 75025-4006 Ph: (214) 919-3500 | Dr Darlene Erica Gou, MD 8080 Independence Pkwy Ste 150, Plano, TX 75025-4006 Ph: (214) 919-3500 |
News Archive
Watson Pharmaceuticals, Inc. has confirmed that it has filed two Abbreviated New Drug Applications (ANDAs) with the U.S. Food and Drug Administration seeking approval to market its guaifenesin extended-release 600mg and 1200mg tablets and its dextromethorphan HBr/guaifenesin extended-release 30mg/600mg and 60mg/1200mg tablets prior to the expiration of patents owned by Reckitt Benckiser Inc.
NxThera, Inc., a medical device company pioneering the application of its Convective Water Vapor Energy (WAVE) platform technology to treat endourological conditions, is pleased to announce it has received FDA 510(k) clearance of the company's Rezūm System to treat BPH.
Iron Mountain Incorporated, the information management company, today announced that the Texas Regional Medical Center (TRMC) has chosen Iron Mountain's vendor neutral archive (VNA) and cloud storage solution to manage its CT scans, MRIs, X-rays and other diagnostic image volume.
Atrial fibrillation is a cardiac arrhythmia - a chronic irregularity of heartbeat - which affects an estimated 1 million people in Germany. Although the condition is not acutely life-threatening, it does increase the risk of developing more serious illnesses, such as cardiac insufficiency, stroke and dementia. In the third of a series of genomewide asssociation studies, an international team of researchers, led by LMU physician PD Dr. Stefan K-b, now reports the identification of a new gene locus that has a significant influence on risk for atrial fibrillation.
There is good news for cancer patients whose medical treatments put them at risk for future cardiac problems: using strain echocardiography can help physicians detect early signs of cardiac toxicity.
› Verified 1 days ago
Sam Awan, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5030 Tennyson Pkwy Ste 100, Plano, TX 75024 Phone: 972-985-9003 Fax: 972-985-1176 | |
Dr. Helena Jenkinson, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 6100 Windhaven Pkwy, Plano, TX 75093 Phone: 972-608-0330 Fax: 214-615-1835 | |
Timothy Robert Allen, MD Dermatology Medicare: Medicare Enrolled Practice Location: 6100 Windhaven Pkwy, Plano, TX 75093 Phone: 214-615-1888 Fax: 706-222-4019 | |
Dr. Elba I Rubianes, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6000 W Spring Creek Pkwy Ste 200, Plano, TX 75024 Phone: 972-316-4555 Fax: 214-285-0791 | |
Dr. Mara Melanie Dacso, M.D Dermatology Medicare: Accepting Medicare Assignments Practice Location: 5044 Tennyson Pkwy, Suite B, Plano, TX 75024 Phone: 972-985-9003 Fax: 972-985-1176 | |
Paul T Martinelli, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3585 National Dr Ste 150, Plano, TX 75025 Phone: 469-467-6647 Fax: 469-467-6648 | |
Dr. Karen Ann Lund, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6100 Windhaven Parkway, Plano, TX 75093 Phone: 972-608-0330 Fax: 972-608-0355 |